AZN News Alert Astrazeneca Plc (AZN) 69.96 02/14/2015 11:15:

New Post Public Reply Private Reply Replies (0) Message Board

Feb 14, 2015 at 12:15 PM

Astrazeneca Plc (AZN) 69.96 $AZN

Is This Company the Big Winner in Obama's Push for Precision Medicine?
Todd Campbell, The Motley Fool - Motley Fool - 2 hrs 18 mins ago
Source: Illumina Inc. President Obama has released more details about his plans to fund a precision medicine initiative that the administration hopes will mean that doctors can deliver the right medicine to the right patient at the right dose ...
JNJ: 99.62 (+1.18), BMRN: 100.76 (+1.98), AZN: 69.96 (+0.20), ILMN: 198.54 (+1.81), BMY: 60.04 (+0.56), SNY: 49.42 (+0.82)

Game-Changing News: Researchers May Have Discovered the Cause of Intestinal Cancer
Sean Williams, The Motley Fool - Motley Fool - Sat Feb 14, 8:12AM CST
Source: Flickr user Erik Soderstrom. Cancer is currently the second-leading cause of death in the United States, and if the World Health Organization is correct, it may wind up eclipsing heart disease for the dubious top spot sometime in the near...
AZN: 69.96 (+0.20), EXAS: 25.56 (-0.54), BMY: 60.04 (+0.56)

1 Sentence That Tells You Everything You Need to Know About Each of These 10 Big Pharma Earnings Rep
Sean Williams, The Motley Fool - Motley Fool - Fri Feb 13, 7:02AM CST
Source: AstraZeneca. Earnings season is more than halfway over, and it hasn't been easy to keep pace with hundreds upon hundreds of earnings reports, sometimes all hitting within the same day. Much of the healthcare sector, especially big...
BIIB: 391.66 (-0.45), JNJ: 99.62 (+1.18), GILD: 101.90 (+1.10), MRK: 58.81 (-0.07), AZN: 69.96 (+0.20), PFE: 34.64 (-0.23), AMGN: 153.48 (+0.30), BMY: 60.04 (+0.56), GSK: 47.94 (+1.99), CELG: 115.88 (+0.16)

Why Regeneron's Risk-Reward Looks Good Again
DoctoRx - at Seeking Alpha - Thu Feb 12, 12:43PM CST

PFE: 34.64 (-0.23), AZN: 69.96 (+0.20), AMGN: 153.48 (+0.30), LLY: 70.56 (+0.03), SNY: 49.42 (+0.82), REGN: 402.40 (+0.66)

AstraZeneca
at Investor's Business Daily - Wed Feb 11, 6:00PM CST
AstraZeneca (AZN) will pay the DOJ $7.9 mil in a kickback settlement over allegations that the pharmaceutical firm paid Medco Health Solutions to ramp up heartburn medication sales. Shares rose 0.3%.
AZN: 69.96 (+0.20)

3 Hold-Rated Dividend Stocks: HSC, AZN, RPT
at The Street - Thu Feb 12, 9:30AM CST
These 3 dividend stocks are rated a Hold by TheStreet
HSC: 17.38 (+0.38), RPT: 19.37 (unch), AZN: 69.96 (+0.20)

Acadia Pharmaceuticals Could Be The Most Sought After Company Of 2015
Investing Healthcare - at Seeking Alpha - Thu Feb 12, 8:40AM CST

ACAD: 34.21 (+0.37), AZN: 69.96 (+0.20), PDP: 42.52 (+0.28), ABBV: 58.05 (+1.00)

The Top ADRs To Buy This Week
Todd Campbell - at Seeking Alpha - Thu Feb 12, 6:40AM CST

RUK: 71.70 (-1.02), BUD: 121.72 (-0.80), ANW: 14.92 (+0.25), DEG: 21.85 (-0.05), ENL: 50.46 (-0.66), FBR: 13.05 (-0.23), SNE: 27.30 (+0.19), TM: 132.49 (+0.67), RDY: 54.15 (-0.01), LUX: 58.79 (-1.11), OMAB: 38.76 (-0.66), TTM: 48.34 (+0.42), SNN: 35.82 (-0.28), RYAAY: 61.46 (-2.33), EDAP: 3.55 (+0.13), AZN: 69.96 (+0.20), TRIB: 17.30 (-0.12), EFA: 63.82 (+0.42), WX: 41.53 (+0.45), TEVA: 56.77 (-0.58)

Why Pfizer Might Not Split Anytime Soon
Emerging Equities - at Seeking Alpha - Wed Feb 11, 3:42PM CST

PFE: 34.64 (-0.23), AZN: 69.96 (+0.20), HSP: 87.35 (unch)

Actavis to Divest U.S. Rights of Doryx to Mayne Pharma - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 10, 2:41PM CST
Actavis (ACT) to divest U.S. rights of Doryx brand to Mayne Pharma, to boost focus on core areas.
IPXL: 39.51 (+0.69), AGN: 229.49 (+1.87), ACT: 285.37 (+3.71), AZN: 69.96 (+0.20)

Glaxo Tries To Turn A Triple Play
EP Vantage - Seeking Alpha - Tue Feb 10, 12:47PM CST
There are several ways in which the treatment paradigm for chronic obstructive pulmonary disease could develop, and GlaxoSmithKline (NYSE: GSK ) has made a firm bet on one of them, yesterday starting a second pivotal trial combining a LAMA with a...
BIIB: 391.66 (-0.45), AZN: 69.96 (+0.20), GSK: 47.94 (+1.99), NVS: 102.20 (-0.17)

Berkshire Hathaway Leads Best Value Long-Term Bond Trades
Donald van Deventer - at Seeking Alpha - Tue Feb 10, 11:40AM CST

72.91 (-0.81), KSS: 68.25 (-0.58), ABX: 12.14 (+0.01), UTX: 121.25 (+1.66), C: 51.20 (+0.31), MO: 54.76 (-0.78), MS: 36.78 (-0.12), PM: 82.87 (-0.82), ANTM: 141.05 (-0.95), JPM: 59.67 (+0.10), AZN: 69.96 (+0.20), DTV: 87.51 (-0.32), MCD: 95.65 (+0.56), CR: 68.19 (-0.40), TWC: 149.74 (+2.21), CAT: 85.13 (+1.60), BRK.B: 148.34 (-1.45), BRK.A: 222,555.00 (-1,905.00), APC: 89.44 (+2.13)

6 Big Pharmaceutical Companies You Don't Want In Your Portfolio
at The Street - Tue Feb 10, 7:17AM CST
Which big pharmaceutical stocks should investors stay away from in 2015?
MNK: 115.01 (+2.51), ENDP: 84.01 (+1.12), JAZZ: 169.69 (+6.89), AZN: 69.96 (+0.20), SLXP: 152.35 (+3.17), GSK: 47.94 (+1.99)

Tetraphase Fights Drug-Resistant Bugs As M&A Heats Up
at Investor's Business Daily - Mon Feb 09, 3:53PM CST
One lesson to draw from recent M&A in the pharma space: Superbug drugs are hot. Last year, Actavis (ACT) plunked down $675 million for Durata Therapeutics, whose drug Dalvance fights some of the nastiest specimens of the class known as gram-positive...
TTPH: 35.18 (-0.73), ACT: 285.37 (+3.71), MDCO: 29.79 (+0.91), AZN: 69.96 (+0.20), MRK: 58.81 (-0.07)

AstraZeneca Might Need More Than Buzzwords To Bridge The Gap
EP Vantage - Seeking Alpha - Mon Feb 09, 1:57PM CST
It is widely appreciated that life is going to get tougher for AstraZeneca (NYSE: AZN ) over the next couple of years as huge patent expiries bite chunks out of its top line. As the company would have it, however, profits will remain far more...
ACT: 285.37 (+3.71), AZN: 69.96 (+0.20), BMY: 60.04 (+0.56), NVS: 102.20 (-0.17)

Theravance Biopharma: GSK Accelerates Study Of High-Potential COPD Therapy
Early Retiree - at Seeking Alpha - Mon Feb 09, 1:43PM CST

AZN: 69.96 (+0.20), TBPH: 18.51 (+0.28), THRX: 14.85 (+1.00), GSK: 47.94 (+1.99)

High Triglyceridemia Therapeutics Pipeline Market H1 2015 Review Report Available at RnRMarketResearch.com
PRWeb - Mon Feb 09, 7:32AM CST
The report "High Triglyceridemia - Pipeline Review, H1 2015″ provides comprehensive information on the therapeutic development for High Triglyceridemia. Triglycerides are the most ordinary form of fat in the body. Triglycerides are the main component in vegetable oils and animal fats. The report strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Complete report is available at http://www.rnrmarketresearch.com/high-triglyc...eport.html.
ISIS: 63.86 (-0.43), AZN: 69.96 (+0.20), NVS: 102.20 (-0.17)

AstraZeneca plc Beefs Up Precision Medicine Arsenal
Maxx Chatsko, The Motley Fool - Motley Fool - Mon Feb 09, 6:02AM CST
Novartis : "Hey, everyone, look over here. I just entered into a collaboration that will give me access to a pretty intriguing genome editing tool. Going to combine it with my top pipeline candidate . It's pretty cool." AstraZeneca : "I see your...
ALNY: 95.54 (+1.67), TMO: 127.61 (+0.78), AZN: 69.96 (+0.20), SGMO: 15.40 (+0.14), NVS: 102.20 (-0.17)

Which Biotech Stock Should Pfizer, Inc. Buy?
Motley Fool Staff, Brian Orelli, Leo Sun, and George Budwell - Motley Fool - Sun Feb 08, 7:02AM CST
Source: Pfizer. Pfizer is struggling to offset slowing sales tied to expiring patents, and that has some observers thinking that Pfizer remains on the hunt to buy another drugmaker that can spark its growth. Earlier this week, Pfizer announced...
BIIB: 391.66 (-0.45), PFE: 34.64 (-0.23), AMGN: 153.48 (+0.30), CLDN: 16.45 (-0.05), BMY: 60.04 (+0.56), GSK: 47.94 (+1.99), CELG: 115.88 (+0.16), SGEN: 31.57 (+0.36), GILD: 101.90 (+1.10), AZN: 69.96 (+0.20), MRK: 58.81 (-0.07)

3 Blockbuster Drugs That May Be Obsolete in 5 Years
Motley Fool Staff - Motley Fool - Sat Feb 07, 12:28PM CST
Blockbuster status is the Holy Grail for drug developers, but patent expirations mean these billion-dollar drugs have a limited shelf life. These three drugs, for example, have been among the planet's best-sellers, but over the course of the next...
JNJ: 99.62 (+1.18), BIIB: 391.66 (-0.45), ESRX: 84.90 (+0.40), PTLA: 34.96 (+3.13), PFE: 34.64 (-0.23), AZN: 69.96 (+0.20), TEVA: 56.77 (-0.58), GSK: 47.94 (+1.99), BMY: 60.04 (+0.56), MNTA: 11.70 (-0.06), NVS: 102.20 (-0.17)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Cogent Communications' Q3 2026 Earnings Call Details

Cue the Countdown: Cogent’s Earnings Call Looms Another quarter rolls by, and with it comes Cogent Communications' chance to strut—or stumble—before the crowd. Their third-quarter earnings call on November 5, 2026, is like the opening bell for a stock that's zipped through more ups and downs than a tired bullfighter's routine. What the call reveals on that crisp...

Wagner Logistics Gears Up for Major Expansion in Liberty

Imagine waking up to news like this: Wagner Logistics is laying down some serious roots in Liberty, MO. They’ve snagged a deal with a local manufacturer that’s got them renting out over 830,000 square feet of warehouse space. Seems Wagner's got a knack for living large. More Than Just a Warehouse Gig Wagner's not just popping up another dusty shelf space; they're...

Vayo Debuts as Booking Holdings Eyes $100M Investment

A travel revolution might just be on the horizon, courtesy of Booking Holdings' latest venture, Vayo. And they’re talking about throwing $100 million into it—subject to a few conditions, sure—but that’s not pocket change you toss around without a serious plan. Transforming Travel into a Seamless Experience Vayo’s got one job: making your travels less like a...

A1 Refrigeration Keeps East Texas Homes Comfortable Year-Round

Homeowners in East Texas would agree: the last thing you want is your HVAC system throwing a tantrum when you're in the thick of a scorching summer or a biting winter. That's where A1 Refrigeration & Air Conditioning steps in, making sure folks in Jasper, Brookeland, and Kirbyville aren't left sweating bullets or shivering in their boots. Preventive Maintenance: A...

FCS Drives Key FDA Approvals in Cancer Treatment

Florida Cancer Specialists: Changing the Cancer Treatment Game Some organizations toot their horns, but every now and then, a group truly shakes up the playing field. Take Florida Cancer Specialists & Research Institute (FCS), for instance. Over years of relentless research, FCS has nailed its role in securing two significant FDA approvals aimed at expanding treatment...

Jaguar Promise Tackles College Cost for Texas Students

Transforming Aspirations into Achievements In the heart of San Antonio, something’s cooking at A&M University-San Antonio, and it's not just the classic breakfast tacos. They've hit a record-breaking enrollment of 7,697 students this Fall, with 1,322 being fresh-faced first-timers. And while that might grab your attention, the real headliner is their Jaguar Promise...

Omega Point's MCP Secures Anthropic Verification

In a world where investment decisions ride on razor-thin margins, Omega Point's MCP gains top-tier verification. Anthropic's seal of approval is stamped firmly on it, signalling to the wise investors out there that this engine ain't smoking mirrors. Since May, this player has been doing the rounds, but now, with Anthropic’s verification, it’s like Omega Point just...

Gourmia Introduces Ceramic-Coated Air Fryer at Costco

A New Era for Home Cooking with Gourmia Stepping into the kitchen appliances arena with a dash of innovation, Gourmia has launched its first ceramic-coated air fryer, and it’s weaving its way exclusively onto the shelves of Costco. Now, it’s not just about frying anymore; it’s about adding style, efficiency, and a touch of healthy living to your countertop. But much...

Oracle Announces AI-Driven QuickStart Platform Launch

NetSuite's AI-First Step into the Market Well, here's the NYSE stirring the pot with Oracle NetSuite's fresh announcement—an AI-first platform called QuickStart. Sounds like they've got their sights set on early-stage tech startups, banking on those little guys to plug into AI tools they've already got in their toolkit. Claude, ChatGPT—these aren't new kids on the...

Truck Drivers USA & Career Driver Unveil New Driver Agent

Revolutionizing Driver-Carrier Connections In today's cranking transportation scene, Truck Drivers USA (TDUSA) and Career Driver have taken a bold step to change up the driver recruitment game. They've launched what's being labeled as the first 'driver agent' within the Career Driver mobile app. It's the talk of the town in Sherwood, Arkansas, these days. This isn't just...